H S Bell

Summary

Affiliation: University of Glasgow
Country: UK

Publications

  1. ncbi Discovery of a perinecrotic 60 kDa MDM2 isoform within glioma spheroids and glioblastoma biopsy material
    H S Bell
    The Beatson Institute for Cancer Research, Garscube Estate, Glasgow, UK
    Neuropathol Appl Neurobiol 31:191-202. 2005
  2. ncbi p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death
    D Crighton
    Tumour Cell Death Laboratory, Beatson Institute for Cancer Research, Cancer Research UK Beatson Laboratories, Garscube Estate, Glasgow, UK
    Cell Death Differ 14:1071-9. 2007
  3. ncbi Heme oxygenase (HO) isoforms in experimental C6 glioma: an immunocytochemical study
    S Lo
    Department of Clinical Neurosciences and Pathology, University of Edinburgh, Western General Hospital, UK
    Br J Neurosurg 15:416-8. 2001
  4. ncbi Antitumour and pro-apoptotic actions of highly unsaturated fatty acids in glioma
    H A Leaver
    Department of Clinical Neurosciences, Edinburgh University, UK
    Prostaglandins Leukot Essent Fatty Acids 66:19-29. 2002
  5. ncbi Highly unsaturated fatty acid induced tumour regression in glioma pharmacodynamics and bioavailability of gamma linolenic acid in an implantation glioma model: effects on tumour biomass, apoptosis and neuronal tissue histology
    H A Leaver
    Department of Clinical Neurosciences, University of Edinburgh, UK
    Prostaglandins Leukot Essent Fatty Acids 67:283-92. 2002
  6. ncbi Glioma tumourgenicity is decreased by iNOS knockout: experimental studies using the C6 striatal implantation glioma model
    S Yamaguchi
    Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, UK
    Br J Neurosurg 16:567-72. 2002

Collaborators

Detail Information

Publications6

  1. ncbi Discovery of a perinecrotic 60 kDa MDM2 isoform within glioma spheroids and glioblastoma biopsy material
    H S Bell
    The Beatson Institute for Cancer Research, Garscube Estate, Glasgow, UK
    Neuropathol Appl Neurobiol 31:191-202. 2005
    ....
  2. ncbi p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death
    D Crighton
    Tumour Cell Death Laboratory, Beatson Institute for Cancer Research, Cancer Research UK Beatson Laboratories, Garscube Estate, Glasgow, UK
    Cell Death Differ 14:1071-9. 2007
    ....
  3. ncbi Heme oxygenase (HO) isoforms in experimental C6 glioma: an immunocytochemical study
    S Lo
    Department of Clinical Neurosciences and Pathology, University of Edinburgh, Western General Hospital, UK
    Br J Neurosurg 15:416-8. 2001
    ..These findings once again demonstrate the differences between human malignant glioma and experimental implantation glioma models...
  4. ncbi Antitumour and pro-apoptotic actions of highly unsaturated fatty acids in glioma
    H A Leaver
    Department of Clinical Neurosciences, Edinburgh University, UK
    Prostaglandins Leukot Essent Fatty Acids 66:19-29. 2002
    ..Also, there was little evidence of acute inflammatory infiltration in regressing tumours. Our findings suggest that intraparenchymal infusion of HUFA may be effective in stimulating glioma regression...
  5. ncbi Highly unsaturated fatty acid induced tumour regression in glioma pharmacodynamics and bioavailability of gamma linolenic acid in an implantation glioma model: effects on tumour biomass, apoptosis and neuronal tissue histology
    H A Leaver
    Department of Clinical Neurosciences, University of Edinburgh, UK
    Prostaglandins Leukot Essent Fatty Acids 67:283-92. 2002
    ..The intraparenchymal route was an effective method of GLA administration in the treatment of glioma. These studies provide further insights into the potential role of HUFAs as anti-glioma agents...
  6. ncbi Glioma tumourgenicity is decreased by iNOS knockout: experimental studies using the C6 striatal implantation glioma model
    S Yamaguchi
    Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, UK
    Br J Neurosurg 16:567-72. 2002
    ..The mechanisms that cause failure of tumour growth need clarification prior to considering that specific iNOS inhibitors might be candidates for adjuvant treatment of malignant glioma...